1684. The Best Way to Predict the Future Is to Create It: ARLG Going Forward
Session: Meet-the-Professor Session: Updates from the Antibacterial Resistance Leadership Group
Saturday, October 6, 2018: 7:55 AM
Room: W 2002
Vance G. Fowler Jr., MD, Duke University, Durham, NC


V. G. Fowler Jr., Cerexa/Actavis/Allergan, Pfizer, Advanced Liquid Logics, NIH, MedImmune, Basilea Pharmaceutica, Karius, ContraFect, Regeneron Pharmaceuticals, and Genentech: Grant Investigator , Grant recipient . Achaogen, Astellas Pharma, Arsanis, Affinergy, AmpliPhi, Basilea Pharmaceutica, Bayer, Cerexa Inc., ContraFect, Cubist, Debiopharm, Durata Therapeutics, Grifols, Genentech, MedImmune, Merck, The Medicines Company, Pfizer, Novartis, NovaDigm Therapeutics: Consultant , Consulting fee . Theravance Biopharma, Inc., and Green Cross: Lecturer , Speaker honorarium . UpToDate: Author , Royalties .

<< Previous Presentation | Next Presentation

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.